None listed
Conditions
Interventions
None listed
Sponsors
Ewha Womans University Seoul Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adults aged 19 years or older.
Exclusion criteria
Exclusion criteria: In this clinical trial, patients who meet any of the following exclusion criteria cannot participate: 1) Patients who have received other drug-eluting stents besides D+Storm 2) Patients with a life expectancy of less than one year 3) Patients with cardiogenic shock 4) Patients with left ventricular ejection fraction less than 30% 5) Women of childbearing potential who are planning to become pregnant during the study period 6) Patients who are considered unsuitable for study participation by the investigator 7) Patients who have scheduled surgery within 12 months of the registration date that requires discontinuation of antiplatelet therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite clinical event of death, myocardial infarction, or target lesion revascularization (TLR) at 12-month follow-up after percutaneous coronary intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| - All-cause mortality - Cardiac death - Myocardial infarction (MI) -Target vessel revascularization (TVR) - Target lesion revascularization (TLR) - Stent thrombosis (per ARC criteria) - Procedural success (defined as final in-hospital angiographic evaluation showing residual stenosis of <30% without occurrence of death, Q-wave myocardial infarction, or urgent repeat revascularization) | — |
Countries
Korea, Republic of
Contacts
Public Contacthyunjoo park
Ewha Womans University Seoul Hospital
Outcome results
None listed